MetaCap

Fennec Pharmaceuticals (FENC) vs Sana Biotechnology (SANA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Fennec Pharmaceuticals (FENC) has outperformed Sana Biotechnology (SANA) over the past year, gaining 66.1% versus a loss of 51.7%. Over five years, FENC leads with a +35.8% price change compared with -91.3% for SANA. Sana Biotechnology is the larger company by market cap ($476.4 million vs $462.1 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

FENC+66.12%SANA-51.67%
+79%+10%-58%
Nov 21, 20251 yearNov 20, 2026
FENC+33.23%SANA-92.54%
+40%-30%-99%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

FENC versus SANA key metrics
MetricFENCSANA
Share price$13.09$1.59
Market cap$462.14M$476.42M
1-day change-2.68%-8.62%
YTD return+70.00%-60.93%
1-year return+66.12%-51.67%
5-year return+35.79%-91.34%
P/E ratio (TTM)436.33—
Forward P/E12.47—
EPS (TTM)$0.03$-0.52
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.64M—
Revenue growth (YoY)-6.09%—
Net income (latest FY)$-9.74M$-244.17M
Operating margin-14.07%—
Net margin-21.82%—
52-week high$13.85$5.49
52-week low$5.65$1.57
Distance from 52-week high-5.49%-71.04%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+34.45%+438.99%
Average volume220.87K3.30M
Shares outstanding35.31M299.63M
Employees35142
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • FENC has outperformed SANA by 117.8 percentage points over the past year.

About Fennec Pharmaceuticals

FENC stock →

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 35 employees

About Sana Biotechnology

SANA stock →

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 142 employees

FENC vs SANA FAQ

Which is bigger, Fennec Pharmaceuticals or Sana Biotechnology?

Sana Biotechnology (SANA) is larger, with a market capitalization of $476.42M compared with $462.14M for Fennec Pharmaceuticals (FENC).

Which stock has performed better over the past year, FENC or SANA?

FENC returned +66.12% over the past 12 months, compared with -51.67% for SANA (price return, excluding dividends). Past performance does not predict future results.

Are Fennec Pharmaceuticals and Sana Biotechnology in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons